Fig. 2From: Seven-year outcomes of combined treatment of anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy; according to polypoidal lesion regressionDistribution of best corrected visual acuity (BCVA) better than 0.3 logMAR and worse than 1.0 logMAR over 84 months. (a) In the regression group. (b) In the persistent groupBack to article page